S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 121 to 160 of 337

Issue Date	Title / Author(s) / Citation	File
2014-05	Hyaluronate-Gold Nanoparticle/Tocilizumab Complex for the Treatment of Rheumatoid Arthritis Lee, Hwiwon; Lee, Min-Young; Bhang, Suk Ho; Kim, Byung-Soo; Kim, Yun Seop; Ju, Ji Hyeon; Kim, Ki Su; Hahn, Sei Kwang ACS Nano, Vol.8 No.5, pp.4790-4798	DOI
2014-06	Mechanisms of paracrine cardioprotection by cord blood mesenchymal stromal cells Bader, Andreas Matthaeus; Brodarac, Andreja; Klose, Kristin; Bieback, Karen; Choi, Yeong-Hoon; Kurtz, Andreas; Stamm, Christof European Journal of Cardio-thoracic Surgery, Vol.45 No.6, pp.983-992	DOI
2014-07	A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HIVI30181A, in Patients with Advanced Solid Cancer Lee, Hyun Jung; Heo, Dae-Seog; Cho, Joo-Youn; Han, Sae-Won; Chang, Hye-Jung; Yi, Hyeon-Gyu; Kim, Tae-Eun; Lee, Se-Hoon; Oh, Do-Youn; Im, Seock-Ah; Jang, In-Jin; Bang, Yung-Jue Cancer Research and Treatment, Vol.46 No.3, pp.234-242	DOI
2014-07	Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy Lee, Hyun Jung; Kim, Dae Young; Keam, Bhumsuk; Lee, Jeong Hoon; Han, Sae-Won; Oh, Do-Youn; Yoon, Jung Hwan; Kim, Tae-You; Kim, Yu Jung; Lee, Keun Wook; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Jong Seok; Kim, Jee Hyun; Im, Seock-Ah Breast Cancer, Vol.21 No.4, pp.387-393	DOI
2014-07	A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Han, Wonshik; Kim, Kyubo; Chie, Eui Kyu; Park, In-Ae; Kim, Young Tae; Noh, Dong-Young; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.46 No.3, pp.280-287	DOI
2014-07	Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma Kim, Byoung Hyuck; Kim, Il Han; Park, Sung-Hye; Park, Chul Kee; Jung, Hee Won; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.3, pp.261-269	DOI
2014-08	Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from Ga-68-RGD PET/CT and F-18-FDG PET/CT Yoon, Hai-Jeon; Kang, Keon Wook; Chun, In Kook; Cho, Nariya; Im, Seock-Ah; Jeong, Sunjoo; Lee, Song; Jung, Kyeong Cheon; Lee, Yun-Sang; Jeong, Jae Min; Lee, Dong Soo; Chung, June-Key; Moon, Woo Kyung European Journal of Nuclear Medicine and Molecular Imaging, Vol.41 No.8, pp.1534-1543	DOI
2014-08	Breast Cancer: Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response Maps for MR Imaging Cho, Nariya; Im, Seock-Ah; Park, In-Ae; Lee, Kyung-Hun; Li, Mulan; Han, Wonshik; Noh, Dong-Young; Moon, Woo Kyung Radiology, Vol.272 No.2, pp.385-396	DOI
2014-08	Multi-modal transfection agent based on monodisperse magnetic. nanoparticles for stem cell gene delivery and tracking Park, Wooram; Yang, Han Na; Ling, Daishun; Yim, Hyeona; Kim, Kyoung Sub; Hyeon, Taeghwan; Na, Kun; Park, Keun-Hong Biomaterials, Vol.35 No.25, pp.7239-7247	DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	view file DOI
2014-10	Eating oysters without risk of vibriosis: Application of a bacteriophage against Vibrio parahaemolyticus in oysters Jun, Jin Woo; Kim, Hyoun Joong; Yun, Sae Kil; Chai, Ji Young; Park, Se Chang International Journal of Food Microbiology, Vol.188, pp.31-35	DOI
2014-11	Targeted Gene Delivery via N-Acetylglucosamine Receptor Mediated Endocytosis Singh, Bijay; Maharjan, Sushila; Kim, You-Kyoung; Jiang, Tao; Islam, Mohammad Ariful; Kang, Sang-Kee; Cho, Myung-Haing; Choi, Yun-Jaie; Cho, Chong-Su Journal of Nanoscience and Nanotechnology, Vol.14 No.11, pp.8356-8364	DOI
2014-11	Bone morphogenetic protein-2 for bone regeneration - Dose reduction through graphene oxide-based delivery La, Wan-Geun; Jung, Moon-Joo; Yoon, Jeong-Kee; Bhang, Suk Ho; Jang, Hyeon-Ki; Lee, Tae-Jin; Yoon, Hee-Hun; Shin, Jung-Youn; Kim, Byung-Soo Carbon, Vol.78, pp.428-438	DOI
2014-12	Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial Jaenne, Pasi A.; Ou, Sai-Hong I.; Kim, Dong-Wan; Oxnard, Geoffrey R.; Martins, Renato; Kris, Mark G.; Dunphy, Frank; Nishio, Makoto; O'Connell, Joseph; Paweletz, Cloud; Taylor, Ian; Zhang, Hui; Goldberg, Zelanna; Mok, Tony The Lancet Oncology, Vol.15 No.13, pp.1433-1441	DOI
2014-12	HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer Lee, Hee Jin; Seo, An Na; Kim, Eun Joo; Jang, Min Hye; Suh, Koung Jin; Ryu, Han Suk; Kim, Yu Jung; Kim, Jee Hyun; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Park, In Ae; Park, So Yeon American Journal of Clinical Pathology, Vol.142 No.6, pp.755-766	DOI
2014-12	Stretchable silicon nanoribbon electronics for skin prosthesis Kim, Jaemin; Lee, Mincheol; Shim, Hyung Joon; Ghaffari, Roozbeh; Cho, Hye Rim; Son, Donghee; Jung, Yei Hwan; Soh, Min; Choi, Changsoon; Jung, Sungmook; Chu, Kon; Jeon, Daejong; Lee, Soon-Tae; Kim, Ji Hoon; Choi, Seung Hong; Hyeon, Taeghwan; Kim, Dae-Hyeong Nature Communications, Vol.5, p. 5747	DOI
2014-12	Clinical Implications of Cefazolin Inoculum Effect and beta-Lactamase Type on Methicillin-Susceptible Staphylococcus aureus Bacteremia Lee, Shinwon; Kwon, Ki Tae; Kim, Hye-In; Chang, Hyun Ha; Lee, Jong-Myung; Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Nam Joong; Oh, Myoung-Don; Song, Do Young; Kim, Shin-Woo Microbial Drug Resistance, Vol.20 No.6, pp.568-574	DOI
2015-05	Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer Song, Ahnah; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Keam, Bhumsuk; Lee, Se-Hoon; Heo, Dae Seog Clinical Cancer Research, Vol.21 No.10, pp.2379-2387	DOI
2015-06	Stretchable Heater Using Ligand-Exchanged Silver Nanowire Nanocomposite for Wearable Articular Thermotherapy Choi, Suji; Park, Jinkyung; Hyun, Wonji; Kim, Jangwon; Kim, Jaemin; Lee, Young Bum; Song, Changyeong; Hwang, Hye Jin; Kim, Ji Hoon; Hyeon, Taeghwan; Kim, Dae-Hyeong ACS Nano, Vol.9 No.6, pp.6626-6633	DOI
2015-06	A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer Kim, Jin Won; Choi, In Sil; Kim, Yu Jung; Lee, Kyung-Hun; Lee, Keun-Wook; Kim, Tae-Yong; Han, Sae-Won; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Im, Seock-Ah; Oh, Do-Youn Cancer Chemotherapy and Pharmacology, Vol.75 No.6, pp.1175-1182	DOI
2015-06	Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer Ock, Chan-Young; Lee, Keun-Wook; Kim, Jin Won; Kim, Jin-Soo; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue; Oh, Do-Youn Clinical Cancer Research, Vol.21 No.11, pp.2520-2529	DOI
2015-07	Engineering of a Biomimetic Pericyte-Covered 3D Microvascular Network Kim, Jaerim; Chung, Minhwan; Kim, Sudong; Jo, Dong Hyun; Kim, Jeong Hun; Jeon, Noo Li PLoS ONE, Vol.10 No.7, p. e0133880	DOI
2015-11	An endoscope with integrated transparent bioelectronics and theranostic nanoparticles for colon cancer treatment Lee, Hyunjae; Lee, Youngsik; Song, Changyeong; Cho, Hye Rim; Ghaffari, Roozbeh; Choi, Tae Kyu; Kim, Kyung Hoon; Lee, Young Bum; Ling, Daishun; Lee, Hyuk; Yu, Su Jong; Choi, Seung Hong; Hyeon, Taeghwan; Kim, Dae-Hyeong Nature Communications, Vol.6, p. 10059	view file DOI
2015-11	Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells Oh, Se Jin; Noh, Kyung Hee; Lee, Young-Ho; Hong, Soon-Oh; Song, Kwon-Ho; Lee, Hyo-Jung; Kim, Soyeon; Kim, Tae Min; Jeon, Ju-Hong; Seo, Jae Hong; Kim, Dong-Wan; Kim, Tae Woo Oncotarget, Vol.6 No.37, pp.40255-40267	view file DOI
2015-12	Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer Ahn, Soo Kyung; Lee, Han-Byoel; Han, Wonshik; Moon, Hyeong-Gon; You, Jee Man; Kim, Jisun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Noh, Dong-Young Annals of Surgical Oncology, Vol.22, pp.S391-S397	DOI
2015-12	Mechanisms of Acquired Resistance to AZD9291 A Mutation-Selective, Irreversible EGFR Inhibitor Kim, Tae Min; Song, Ahnah; Kim, Dong-Wan; Kim, Soyeon; Ahn, Yong-Oon; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.10 No.12, pp.1736-1744	DOI
2015-12	Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy Kim, Ji-Won; Min, Chang-Ki; Mun, Yeung-Chul; Park, Yong; Kim, Byung Soo; Nam, Seung-Hyun; Koh, Youngil; Kwon, Ji-Hyun; Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Inho Journal of Clinical Virology, Vol.73, pp.64-69	DOI
2016-01	Reduced dose intensities of doxorubicin in elderly patients with DLBCL in rituximab era Ha, Hyerim; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Heo, Dae Seog Cancer Research and Treatment, Vol.48 No.1, pp.304-311	view file DOI
2016-02	Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02) Lee, Ji Yun; Xu Qing; Wei Xiumin; Bai Yali; Chi, Sangah; Bak, So Hyeon; Lee, Ho Yun; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Cho, Eun Kyung; Kim, Dong-Wan; Kim, Hye Ryun; Min, Young Joo; Jung, Sin-Ho; Park, Keunchil; Mao Mao; Ahn, Myung-Ju Oncotarget, Vol.7 No.6, pp.6984-6993	view file DOI
2016-03	Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors Sim, Sung Hoon; Beom, Seung-Hoon; Ahn, Yong-Oon; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thoracic Cancer, Vol.7 No.2, pp.161-166	view file DOI
2016-03	Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy Kim, Hyori; Youk, Jeonghwan; Yang, Yaewon; Kim, Tae-Yong; Min, Ahrum; Ham, Hye-Seon; Cho, Seongcheol; Lee, Kyung-Hun; Keam, Bhumsuk; Han, Sae-Won; Oh, Do-Youn; Ryu, Han Suk; Han, Wonshik; Park, In Ae; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Journal of Cancer Research and Clinical Oncology, Vol.142 No.3, pp.707-714	DOI
2016-03	Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, KyoungBun; Kim, Kyubo; Lee, Kyung-Hun; Han, Sae-Won; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Bang, Yung-Jue PLoS ONE, Vol.11 No.3, p. e0151406	DOI
2016-03	Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease Nam, Eun Young; Song, Kyoung-Ho; Kim, Nak-Hyun; Kim, Moonsuk; Kim, Chung-Jong; Lee, Jeong-Ok; Choe, Pyoeng Gyun; Park, Wan Beom; Bang, Ji-Hwan; Kim, Eu Suk; Park, Sang-Won; Kim, Hong Bin; Bang, Soo-Mee; Kim, Nam Joong; Oh, Myoung-don International Journal of Infectious Diseases, Vol.44, pp.4-7	DOI
2016-03	Isolation and comparative genomic analysis of T1-Like Shigella bacteriophage pSf-2 Jun, Jin Woo; Kim, Hyoun Joong; Yun, Sae Kil; Chai, Ji Young; Lee, Byeong Chun; Park, Se Chang Current Microbiology, Vol.72 No.3, pp.235-241	DOI
2016-03	Substitution of heavy complementarity determining region 3 (CDR-H3) residues can synergistically enhance functional activity of antibody and its binding affinity to HER2 antigen Moon, Seung Kee; Park, So Ra; Park, Ami; Oh, Hyun Mi; Shin, Hyun Jung; Jeon, Eun Ju; Kim, Seiwhan; Park, Hyun June; Yeon, Young Joo; Yoo, Young Je Molecules and Cells, Vol.39 No.3, pp.217-228	view file DOI
2016-04	Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma Ock, Chan-Young; Son, Bongjun; Keam, Bhumsuk; Lee, Seung-Youn; Moon, Jaewoo; Kwak, Hwanjong; Kim, Sehui; Kim, Tae Min; Jeon, Yoon Kyung; Kwon, Seong Keun; Hah, J. Hun; Lee, Se-Hoon; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.142 No.4, pp.873-883	DOI
2016-04	Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Herbst, Roy S.; Baas, Paul; Kim, Dong-Wan; Felip, Enriqueta; Perez-Gracia, Jose L.; Han, Ji-Youn; Molina, Julian; Kim, Joo-Hang; Arvis, Catherine Dubos; Ahn, Myung-Ju; Majem, Margarita; Fidler, Mary J.; de Castro, Gilberto, Jr.; Garrido, Marcelo; Lubiniecki, Gregory M.; Shentu, Yue; Im, Ellie; Dolled-Filhart, Marisa; Garon, Edward B. The Lancet, Vol.387 No.10027, pp.1540-1550	DOI
2016-04	Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies Planchard, David; Brown, Kathryn H.; Kim, Dong-Wan; Kim, Sang-We; Ohe, Yuichiro; Felip, Enriqueta; Leese, Philip; Cantarini, Mireille; Vishwanathan, Karthick; Jaenne, Pasi A.; Ranson, Malcolm; Dickinson, Paul A. Cancer Chemotherapy and Pharmacology, Vol.77 No.4, pp.767-776	DOI
2016-05	The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): Study protocol for a randomized controlled trial and progress Kim, Hyun-Ah; Ahn, Sei Hyun; Nam, Seok Jin; Park, Seho; Ro, Jungsil; Im, Seock-Ah; Jung, Yong Sik; Yoon, Jung Han; Hur, Min Hee; Choi, Yoon Ji; Lee, Soo-Jung; Jeong, Joon; Cho, Se-Heon; Kim, Sung Yong; Lee, Min Hyuk; Kim, Lee Su; Moon, Byung-In; Kim, Tae Hyun; Park, Chanheun; Kim, Sei Joong; Jung, Sung Hoo; Park, Heungkyu; Gwak, Geum Hee; Kang, Sun Hee; Kim, Jong Gin; Kim, Jeryong; Choi, Su Yun; Lim, Cheol-Wan; Kim, Doyil; Yoo, Youngbum; Song, Young-Jin; Kang, Yoon-Jung; Jung, Sang Seol; Shin, Hyuk Jai; Lee, Kwan Ju; Han, Se-Hwan; Lee, Eun Sook; Han, Wonshik; Kim, Hee-Jung; Noh, Woo Chul BMC Cancer, Vol.16, p. 319	DOI
2016-05	Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial Park, Keunchil; Tan, Eng-Huat; O'Byrne, Ken; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kolbeck, Arvis Karl; Laurie, Scott A.; Tsai, Chun-Ming; Shahidi, Mehdi; Kim, Miyoung; Massey, Dan; Zazulina, Victoria; Paz-Ares, Luis The Lancet Oncology, Vol.17 No.5, pp.577-589	DOI

1 2 3 4 5 6 9